辰欣药业(603367) - 2019 Q1 - 季度财报

Financial Performance - Operating revenue for the period was ¥992,537,792.51, representing a 4.74% increase from the same period last year[12] - Net profit attributable to shareholders of the listed company was ¥127,641,361.07, up 6.46% year-on-year[12] - Basic earnings per share were ¥0.28, compared to ¥0.26 in the same period last year[12] - Total operating revenue for Q1 2019 was CNY 992,537,792.51, an increase from CNY 947,611,114.24 in Q1 2018, representing a growth of approximately 4.6%[35] - The company's net profit for Q1 2019 was CNY 127,734,820.10, an increase from CNY 119,826,197.51 in Q1 2018, representing a growth of approximately 7.9%[39] - Total profit for Q1 2019 was CNY 145,140,014.30, compared to CNY 144,784,381.65 in Q1 2018, showing a marginal increase of about 0.2%[39] Assets and Liabilities - Total assets at the end of the reporting period reached ¥5,334,363,849.31, an increase of 1.64% compared to the end of the previous year[12] - The company's total assets as of March 31, 2019, amounted to CNY 5,105,339,457.38, up from CNY 5,048,614,300.85 at the end of 2018[33] - Total liabilities decreased from CNY 1,093,391,974.33 to CNY 1,051,676,899.18[27] - The total liabilities decreased to CNY 916,873,678.40 from CNY 956,367,324.03, showing a reduction of approximately 4.1%[35] Cash Flow - Net cash flow from operating activities was ¥3,666,676.17, a significant decrease of 95.58% compared to the previous year[12] - The net cash flow from operating activities for Q1 2019 was CNY 3,666,676.17, a significant decrease from CNY 82,871,837.14 in the same period last year[47] - The company reported a net cash flow from financing activities of CNY -14,541,847.71 in Q1 2019, indicating a decrease in cash from financing sources[50] Shareholder Information - The total number of shareholders at the end of the reporting period was 32,589[14] - The top shareholder, Zunyi Qianding Enterprise Management Co., Ltd., held 165,673,200 shares, accounting for 36.54% of the total[14] Expenses - Management expenses increased by 77.61% from CNY 24,779,186.10 to CNY 44,009,564.11[17] - R&D expenses surged by 132.05% from CNY 46,666,082.68 to CNY 108,290,407.73[17] - Tax payable increased by 59.54% from CNY 36,620,406.04 to CNY 58,423,900.16[17] - The tax expenses for Q1 2019 were CNY 17,405,194.20, down from CNY 24,958,184.14 in Q1 2018, indicating a decrease of about 30.3%[39] Income and Other Financial Metrics - Investment income rose by 235.36% from CNY 8,436,575.71 to CNY 28,292,548.02[17] - Other income for Q1 2019 was CNY 3,283,473.40, compared to CNY 5,011,572.30 in Q1 2018, reflecting a decline of approximately 34.5%[39] - The company's cash inflows from sales of goods and services reached CNY 760,697,984.50 in Q1 2019, up from CNY 714,118,890.40 in Q1 2018[47] Current Assets - The company's cash and cash equivalents increased from CNY 345,761,052.87 to CNY 353,231,113.90[21] - The total current assets amounted to CNY 3,612,295,119.21, an increase from CNY 3,564,595,487.57 in the previous year[33]